Form D · Pharmaceuticals
KALIDEX PHARMACEUTICALS, INC.
Menlo Park, CA · CIK 0001505215
Offering snapshot reported Mar 9, 2011 · SEC filing
- Reported sold
- $8.25M Offering amount: $45M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2011 | Initial | $8,249,998 | No comparison | 8 | SEC filing |
| Nov 10, 2010 | Initial | $250,628 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-156449
Source: Form D, filed Mar 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brent Ahrens | Director |
| Shelley Chu | Director |
| Yigong (James) Ge | Director, Executive |
| Patrick Heron | Director |
| Ron Hunt | Director |
| Chun (Vernon) Jiang | Executive |
| Gary Patou | Director |
| Dennis Podlesak | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
70 Willow Road Suite 200
Menlo Park, CA, 94025
Menlo Park, CA, 94025